MedTrace Logo

Remifentanil for General Anesthesia in Preeclamptics

NCT00567957 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2007-12-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether remifentanil use in preeclamptic patients may blunt hemodynamic response to intubation during general anesthesia for cesarean section.

Conditions

  • Pre-Eclampsia
  • Hypertension, Pregnancy-Induced
  • Pregnancy Complications

Interventions

DRUG

Remifentanil

1 microg/kg iv bolus before induction followed by 0.5 microg/kg/min infusion

DRUG

Saline

same volume iv bolus before induction followed by same volume infusion

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Tulay Ozkan Seyhan, Associate Prof · Istanbul University

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Completion
2009-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00567957 on ClinicalTrials.gov